Ana Silvia González-Méndez

Dr. Ana Silvia González-Méndez

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Virus Research
Verified
Journal Article
Closed access
AGAna Silvia González-Méndez
Ana Silvia González-Méndez
FTFernando Cerón Téllez
Fernando Cerón Téllez
JPJorge Luis Tórtora Pérez
Jorge Luis Tórtora Pérez
HRHumberto Alejandro Martínez Rodríguez
Humberto Alejandro Martínez Rodríguez
MFMaria Martha Garcia Flores
Maria Martha Garcia Flores
Hugo Ramírez ÁlvarezHugo Ramírez Álvarez
Hugo Ramírez Álvarez

1 March 2020 in Virus Research
Verified
Journal Article
Closed access
FTFernando Cerón Téllez
Fernando Cerón Téllez
AGAna Silvia González-Méndez
Ana Silvia González-Méndez
JPJorge Luis Tórtora Pérez
Jorge Luis Tórtora Pérez
ELElizabeth Loza-Rubio
Elizabeth Loza-Rubio
Hugo Ramírez ÁlvarezHugo Ramírez Álvarez
Hugo Ramírez Álvarez

14 October 2021 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
NMNeli Montero Machuca
Neli Montero Machuca
JPJorge Luis Tórtora Pérez
Jorge Luis Tórtora Pérez
AGAna Silvia González-Méndez
Ana Silvia González-Méndez
AGAngélica Lucia García-Camacho
Angélica Lucia García-Camacho
Ernesto Marín FlamandErnesto Marín Flamand
Ernesto Marín Flamand
Hugo Ramírez ÁlvarezHugo Ramírez Álvarez
Hugo Ramírez Álvarez

4 September 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
AGAna Silvia González-Méndez
Ana Silvia González-Méndez
MAMohammad Mehdi Akbarin
Mohammad Mehdi Akbarin
FCFernando Cerón-Téllez
Fernando Cerón-Téllez
GAGabriel Eduardo Acevedo-Jiménez
Gabriel Eduardo Acevedo-Jiménez
CRCecilia Rodríguez-Murillo
Cecilia Rodríguez-Murillo
Hugo Ramírez ÁlvarezHugo Ramírez Álvarez
Hugo Ramírez Álvarez
Introduction: Bovine leukemia virus is a single-stranded RNA virus that targets B cell CD5+ lymphocytes in cattle. Only a tiny percentage of individuals develop malignant lymphoproliferative disorders, while most remain healthy carriers or experience persistent lymphocytosis. The exact mechanisms leading to lymphoma development are complex and not fully understood. RNA-seq analysis of cows’ peripheral blood leukocytes (PBLs) with and without Bovine leukemia virus (BLV) antibodies was conducted to gain a deeper understanding of molecular events beyond BLV infection. Method: Eighteen samples were selected, and their RNA was sequenced. For gene expression analysis and protein–protein network interactions, three groups were selected, including healthy negative samples (CT, n = 7), asymptomatic carriers (AC, n = 5), and persistent lymphocytosis (PL, n = 6), to provide the differentially expressed gene (DEG) and protein–protein interaction network (PPIN) outputs. Results: Our results demonstrated that in comparison to CT, ACs upregulated TLR7 and transcription activation factors. In the CT vs. PL group, MHC class II, transcription activation factors, and anti-inflammatory cytokines increased, while the acute-phase proteins, antiviral receptors, and inflammatory cytokines decreased. Additionally, antiviral receptors, acute-phase proteins, and inflammatory receptors were downregulated in the PL versus the AC groups. Moreover, PPINs analysis suggested that nuclear receptor corepressor 1 (NCOR1), serine/arginine repetitive matrix 2 (SRRM2), LUC7 like 3 pre-mRNA splicing factor (LUC7L3), TWIST neighbor (TWISTNB), U6 small nuclear RNA and mRNA degradation associated (LSM4), eukaryotic translation elongation factor 2 (EEF2), ubiquitin C (UBC), CD74, and heterogeneous nuclear ribonucleoprotein A2/B1 (HNRNP A2B1) are possible hub gene candidates in the PL group. Conclusions: Our results suggest that innate and cellular immune responses are more loose in severe BLV infectious conditions, while the PPINs revealed that new protein interactions are necessary for oncogenesis.

29 March 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
AGAna Silvia González-Méndez
Ana Silvia González-Méndez
JPJorge L. Tórtora Pérez
Jorge L. Tórtora Pérez
EREDITH ROJAS-ANAYA
EDITH ROJAS-ANAYA
Hugo Ramírez ÁlvarezHugo Ramírez Álvarez
Hugo Ramírez Álvarez
The goal of this study was to analyze the genetic expression of antiretroviral restriction factors (ARF) and acute phase proteins (APP), as well as their correlation with proviral and viral loads in cattle with aleukemic (AL) and persistent lymphocytosis (PL). Complete blood samples were collected from a herd of dairy cows, and we extracted genetic material from peripheral blood leukocytes. Absolute quantification of the expression of ARF (APOBEC-Z1, Z2, and Z3; HEXIM-1, HEXIM-2, and BST2) and APP (haptoglobin (HP), and serum amyloid A (SAA)) was performed by qPCR. Statistical significance was observed in the expression of APOBEC-Z3 in BLV-infected animals. We only found positive correlations with a strong expression of the ARF genes in the AL group. The participation of APOBEC (Z1 and Z3), HEXIM-1, and HEXIM-2 was more frequently identified in BLV-infected animals. HEXIM-2 showed active gene expression in the AL group. Although the expression of ARF in early stages of infection (AL) maintains an important participation, in late stages (PL) it seems to have little relevance.